227 related articles for article (PubMed ID: 9422538)
21. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical detection of E2F-1 in non-Hodgkin's lymphomas: a survey of 124 cases.
Lai R; Medeiros LJ; Coupland R; McCourty A; Brynes RK
Mod Pathol; 1998 May; 11(5):457-63. PubMed ID: 9619599
[TBL] [Abstract][Full Text] [Related]
23. Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma.
Yao J; Pollock RE; Lang A; Tan M; Pisters PW; Goodrich D; El-Naggar A; Yu D
Clin Cancer Res; 1998 Apr; 4(4):1065-70. PubMed ID: 9563903
[TBL] [Abstract][Full Text] [Related]
24. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
Xerri L; Chetaille B; Serriari N; Attias C; Guillaume Y; Arnoulet C; Olive D
Hum Pathol; 2008 Jul; 39(7):1050-8. PubMed ID: 18479731
[TBL] [Abstract][Full Text] [Related]
25. Formation of p27-CDK complexes during the human mitotic cell cycle.
Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
[TBL] [Abstract][Full Text] [Related]
26. Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma.
Sasaki E; Yatabe Y; Hashimoto M; Yamashita Y; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Pathol Int; 2007 Feb; 57(2):53-9. PubMed ID: 17300668
[TBL] [Abstract][Full Text] [Related]
27. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-MartÃnez L; Fend F
Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
[TBL] [Abstract][Full Text] [Related]
28. Low levels of cyclin D and nonfunctional Rb protein affect cdk6 association with cyclin-dependent kinase inhibitor p27(Kip1).
Kwon TK; Park JW
Biochem Biophys Res Commun; 2001 Jun; 284(1):106-11. PubMed ID: 11374878
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma.
Fosmire SP; Thomas R; Jubala CM; Wojcieszyn JW; Valli VE; Getzy DM; Smith TL; Gardner LA; Ritt MG; Bell JS; Freeman KP; Greenfield BE; Lana SE; Kisseberth WC; Helfand SC; Cutter GR; Breen M; Modiano JF
Vet Pathol; 2007 Jul; 44(4):467-78. PubMed ID: 17606508
[TBL] [Abstract][Full Text] [Related]
30. Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases.
Okuda T; Hirai H; Valentine VA; Shurtleff SA; Kidd VJ; Lahti JM; Sherr CJ; Downing JR
Genomics; 1995 Oct; 29(3):623-30. PubMed ID: 8575754
[TBL] [Abstract][Full Text] [Related]
31. Alterations of the putative tumor suppressor gene p16/MTS1 in human hematological malignancies.
Duro D; Flexor MA; Bernard O; d'Agay MF; Berger R; Larsen CJ
C R Acad Sci III; 1994 Oct; 317(10):913-9. PubMed ID: 7882134
[TBL] [Abstract][Full Text] [Related]
32. Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes.
Lucas JJ; Szepesi A; Modiano JF; Domenico J; Gelfand EW
J Immunol; 1995 Jun; 154(12):6275-84. PubMed ID: 7759865
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
[TBL] [Abstract][Full Text] [Related]
34. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
35. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA.
Costello JF; Plass C; Arap W; Chapman VM; Held WA; Berger MS; Su Huang HJ; Cavenee WK
Cancer Res; 1997 Apr; 57(7):1250-4. PubMed ID: 9102208
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias.
Hayette S; Thomas X; Bertrand Y; Tigaud I; Callanan M; Thiebaut A; Charrin C; Archimbaud E; Magaud JP; Rimokh R
Leukemia; 1997 Oct; 11(10):1696-9. PubMed ID: 9324291
[TBL] [Abstract][Full Text] [Related]
37. Rapid nuclear translocation and increased activity of cyclin-dependent kinase 6 after T cell activation.
Nagasawa M; Melamed I; Kupfer A; Gelfand EW; Lucas JJ
J Immunol; 1997 Jun; 158(11):5146-54. PubMed ID: 9164930
[TBL] [Abstract][Full Text] [Related]
38. BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus.
Hyjek E; Chadburn A; Liu YF; Cesarman E; Knowles DM
Blood; 2001 Jan; 97(1):270-6. PubMed ID: 11133771
[TBL] [Abstract][Full Text] [Related]
39. NOTCH1 intracellular domain immunohistochemistry as a diagnostic tool to distinguish T-lymphoblastic lymphoma from thymoma.
Jegalian AG; Bodo J; Hsi ED
Am J Surg Pathol; 2015 Apr; 39(4):565-72. PubMed ID: 25517959
[TBL] [Abstract][Full Text] [Related]
40. LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma.
Jevremovic D; Roden AC; Ketterling RP; Kurtin PJ; McPhail ED
Am J Clin Pathol; 2016 Feb; 145(2):180-90. PubMed ID: 26796495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
